Cargando…
Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance
Regardless of the significant improvements in treatment of melanoma, the majority of patients develop resistance whose mechanisms are still not completely understood. Hence, we generated and characterized two melanoma-derived cell lines, primary WM793B and metastatic A375M, with acquired resistance...
Autores principales: | Radić, Martina, Vlašić, Ignacija, Jazvinšćak Jembrek, Maja, Horvat, Anđela, Tadijan, Ana, Sabol, Maja, Dužević, Marko, Herak Bosnar, Maja, Slade, Neda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455970/ https://www.ncbi.nlm.nih.gov/pubmed/36077308 http://dx.doi.org/10.3390/ijms23179910 |
Ejemplares similares
-
p53 Family in Resistance to Targeted Therapy of Melanoma
por: Vlašić, Ignacija, et al.
Publicado: (2022) -
p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies
por: Horvat, Anđela, et al.
Publicado: (2021) -
Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
por: Tadijan, Ana, et al.
Publicado: (2022) -
The Subcellular Localization and Oligomerization Preferences of NME1/NME2 upon Radiation-Induced DNA Damage
por: Radić, Martina, et al.
Publicado: (2020) -
Neurotoxic Effect of Flavonol Myricetin in the Presence of Excess Copper
por: Sadžak, Anja, et al.
Publicado: (2021)